2Fluit AC,Jones ME,Schmitz FJ,et al.Antimicrobial resistance among urinary tract infection[UTI] isolates in Europe; results from the SENTRY antimicrobial surveillance pogram 1997[M].Antonic Van Leeuwenboek,2000,147-152.
3Farreu J,Morrissey I,de Rubeis D,et al.AUK multicentre study of the antimicrobial.susceptibility of bacterial pathogens causing urinary tract infection[J].J Infect,2003,46(2):94-100.
6Szabo D,Barcs I,Rozgonyi F.Extended -speetrum beta-lactamases:an actual problem of hospital microbiology (a review)[J].Acta Microbiol Immunol Hung,1997,44(4):309 -325.
2Kania I, Gospodarek E, Ulatowska B. Analysis of the bacterial stains isolated from urine samples of hospitalized and ambulatory patients[J]. Med Sci Monit ,2000, 6:1122-1127
3Fluit AC, Jones ME, Schmitz FJ, et al.Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: results from the SENTRY antimicrobial surveillance program 1997[J]. Antonie Van Leeuwenhoek, 2000,77:147-152
1Coudron PE, Moland ES, Thomson KS. Occurrence anddetection of AmpC beta-lactamases among Escherichiacoli.Klebsiella pneumoniae.and Proteus mirabilis isolatesat a veterans medical center[J]. J Clin Microbiol . 2000,38(5):1791-1796.
2Bush K,Jacoby GA,Medeiros AA. A functional classifica-tion scheme for beta-lactamases and its correlation withmolecular structure [J]. Antimicrob Agents Chemother,1995,39(6):1211-1233.
3Ben-Ami R. A multinational survey of risk factors for in-fection with extended-spectrum beta-lactamase-producingenterobacteriaceae in nonhospitalized patients[J]. Clin In-fect Dis,2009,49(5):682-690.
4Bradford PA. Extended-spectrum beta-lactamases in the21st century : characterization, epidemiology, and detectionof this important resistance threat [J]. Clin MicrobiolRev,2001,14(4) :933-951.
5Clinical and Laboratory Standards Institute. M100-S17.Performance standards for antimicrobial susceptibilitytesting:eighteenth informational supplement[S]. Wayne,PA:CLSI,2008.
6Mukherjee M,Basu S,Mukherjee SK,et al. Multidrug-re-sistance and extended spectrum beta-lactamase productionin uropathogenic E. coli which were isolated from hospi-talized patients in Kolkata, India [J]. J Clin Diagn Res,2013,7(3):449-453.
7Islam MS, Yusuf MA, Islam MB, et al. Frequency of ES-BL in Surgical Site Infection at a Tertiary Care Hospital[J]. J Curr Adv Med Res,2014,1(2) :25-29.
9Chander A,Shrestha CD. Prevalence of extended spec-trum beta lactamase producing Escherichia coli and Kleb-siella pneumoniae urinary isolates in a tertiary care hospi-tal in Kathmandu,Nepal [J]. BMC Res Notes, 2013 , 6 :487-492.
10Colodner R,Rock W,Chazan B,et al. Risk factors for thedevelopment of extended-spectrum beta-lactamase produ-cing bacteria in nonhospitalized patients [J]. Eur J ClinMicrobiol Infect Dis,2004,23(3) :163-167.
